Mydecine Innovations Group (STU:0NF0) Other Long Term Assets : €0.34 Mil (As of Sep. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Mydecine Innovations Group Other Long Term Assets?

Mydecine Innovations Group's other long-term assets for the quarter that ended in Sep. 2023 was €0.34 Mil.

Mydecine Innovations Group's quarterly other long-term assets increased from Mar. 2023 (€0.31 Mil) to Jun. 2023 (€0.32 Mil) and increased from Jun. 2023 (€0.32 Mil) to Sep. 2023 (€0.34 Mil).

Mydecine Innovations Group's annual other long-term assets increased from Dec. 2020 (€1.11 Mil) to Dec. 2021 (€1.24 Mil) but then declined from Dec. 2021 (€1.24 Mil) to Dec. 2022 (€0.47 Mil).

Mydecine Innovations Group Other Long Term Assets Historical Data

The historical data trend for Mydecine Innovations Group's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mydecine Innovations Group Other Long Term Assets Chart

Mydecine Innovations Group Annual Data

Trend

Dec13

Aug14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Long Term Assets

Get a 7-Day Free Trial

0.93

0.95

1.11

1.24

0.47

Mydecine Innovations Group Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Other Long Term Assets	Get a 7-Day Free Trial															0.74	0.47	0.31	0.32	0.34

Mydecine Innovations Group Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Mydecine Innovations Group (STU:0NF0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mydecine Innovations Group Inc (STU:0NF0) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

MYCOF:USA MYIG:UK MYCO:Canada

Address

789 West Pender Street, Suite 810, Vancouver, BC, CAN, V6C 1H2

Website

https://www.mydecine.com

Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.

Mydecine Innovations Group (STU:0NF0) Headlines

No Headlines